Gene Therapies For Cardiomyopathies Therapeutics Market Report 2024: Current Treatment Patterns, Clinical Assessment of Products, Pipeline Development Activities
July 18, 2024 07:16 ET
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapies For Cardiomyopathies - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.Gene Therapies For...
Gene Therapy Agreements Analysis Report and Directory 2024: Comprehensive Listing of 740 Deals Announced Since 2016
July 17, 2024 05:31 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gene Therapy Collaboration and...
California Institute for Regenerative Medicine (CIRM) Appoints New CEO
July 10, 2024 15:30 ET
|
California Institute for Regenerative Medicine (CIRM)
South San Francisco, California, July 10, 2024 (GLOBE NEWSWIRE) -- The Independent Citizens’ Oversight Committee (ICOC), the governing board of the California Institute for Regenerative Medicine...
Neha Motwani Elected to Longeveron® Board of Directors
July 09, 2024 09:00 ET
|
Longeveron
Neha Motwani, a senior healthcare investment banker, has been elected to the Longeveron Board of Directors
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
July 09, 2024 07:05 ET
|
uniQure Inc.
~ Achieved statistically significant, dose-dependent, and durable evidence of potential therapeutic benefit; Patients receiving high-dose AMT-130 showed 80% slowing of disease progression in the...
Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors
July 08, 2024 09:00 ET
|
Longeveron
Gene therapy pioneer Dr. Roger Hajjar elected to Longeveron Board of Directors as company advances it novel cellular therapy across multiple indications.
Viral Vector Manufacturing Industry Research 2024
July 03, 2024 10:26 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
July 02, 2024 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and...
Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting
July 02, 2024 08:00 ET
|
Bionano Genomics
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on the...
Gene Therapy R&D Market Report 2024-2034 - Gene Therapy Resurgence Fuelled by Groundbreaking Advancements, Soaring Investments and a Promising Pipeline Reshaping Medicine's Future
July 01, 2024 10:10 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy R&D Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. World revenue for Gene Therapy R&D Market is...